Date of Patent: Apr. 09, 2019 Applicant:
Takeda Pharmaceutical Company Limited , Chuo-ku, Osaka-shi, Osaka, JP ;
Inventors:
Ryo Mizojiri , Kanagawa, JP ;
Moriteru Asano , Kanagawa, JP ;
Daisuke Tomita , Kanagawa, JP ;
Hiroshi Banno , Kanagawa, JP ;
Michiko Tawada , Kanagawa, JP ;
Noriyuki Nii , Kanagawa, JP ;
Krista E. Gipson , Medford, MA (US) ;
Hironobu Maezaki , Kanagawa, JP ;
Shuntarou Tsuchiya , Kanagawa, JP ;
Mayumi Imai , Kanagawa, JP ;
Yuichiro Amano , Kanagawa, JP ;
Int. Cl.
CPC ...
C07D 213/65 (2006.01) ; A61K 31/165 (2006.01) ; A61K 31/167 (2006.01) ; A61K 31/277 (2006.01) ; A61K 31/381 (2006.01) ; A61K 31/402 (2006.01) ; A61K 31/415 (2006.01) ; A61K 31/42 (2006.01) ; A61K 31/421 (2006.01) ; A61K 31/426 (2006.01) ; A61K 31/427 (2006.01) ; A61K 31/44 (2006.01) ; A61K 31/4412 (2006.01) ; A61K 31/4436 (2006.01) ; A61K 31/4439 (2006.01) ; A61K 31/444 (2006.01) ; A61K 31/451 (2006.01) ; A61K 31/454 (2006.01) ; A61K 31/4965 (2006.01) ; A61K 31/50 (2006.01) ; A61K 31/501 (2006.01) ; A61K 31/505 (2006.01) ; A61K 31/506 (2006.01) ; C07D 213/75 (2006.01) ; C07D 213/81 (2006.01) ; C07D 231/12 (2006.01) ; C07D 333/20 (2006.01) ; C07D 401/04 (2006.01) ; C07D 237/14 (2006.01) ; C07D 239/34 (2006.01) ; C07D 409/04 (2006.01) ; C07D 413/04 (2006.01) ; C07D 241/18 (2006.01) ; C07D 417/04 (2006.01) ; C07C 233/18 (2006.01) ; C07C 233/47 (2006.01) ; C07D 261/08 (2006.01) ; C07D 263/32 (2006.01) ; C07D 263/42 (2006.01) ; C07D 207/08 (2006.01) ; C07D 207/12 (2006.01) ; C07D 277/34 (2006.01) ; C07D 211/44 (2006.01) ; C07D 213/643 (2006.01) ; C07D 213/69 (2006.01) ; C07C 233/25 (2006.01) ; C07C 255/54 (2006.01) ; C07D 211/46 (2006.01) ; C07D 213/74 (2006.01) ; C07D 401/12 (2006.01) ; C12N 9/99 (2006.01) ; C12N 15/09 (2006.01) ;
U.S. Cl.
CPC ...
C07D 213/65 (2013.01) ; A61K 31/165 (2013.01) ; A61K 31/167 (2013.01) ; A61K 31/277 (2013.01) ; A61K 31/381 (2013.01) ; A61K 31/402 (2013.01) ; A61K 31/415 (2013.01) ; A61K 31/42 (2013.01) ; A61K 31/421 (2013.01) ; A61K 31/426 (2013.01) ; A61K 31/427 (2013.01) ; A61K 31/44 (2013.01) ; A61K 31/444 (2013.01) ; A61K 31/4412 (2013.01) ; A61K 31/4436 (2013.01) ; A61K 31/4439 (2013.01) ; A61K 31/451 (2013.01) ; A61K 31/454 (2013.01) ; A61K 31/4965 (2013.01) ; A61K 31/50 (2013.01) ; A61K 31/501 (2013.01) ; A61K 31/505 (2013.01) ; A61K 31/506 (2013.01) ; C07C 233/18 (2013.01) ; C07C 233/25 (2013.01) ; C07C 233/47 (2013.01) ; C07C 255/54 (2013.01) ; C07D 207/08 (2013.01) ; C07D 207/12 (2013.01) ; C07D 211/44 (2013.01) ; C07D 211/46 (2013.01) ; C07D 213/643 (2013.01) ; C07D 213/69 (2013.01) ; C07D 213/74 (2013.01) ; C07D 213/75 (2013.01) ; C07D 213/81 (2013.01) ; C07D 231/12 (2013.01) ; C07D 237/14 (2013.01) ; C07D 239/34 (2013.01) ; C07D 241/18 (2013.01) ; C07D 261/08 (2013.01) ; C07D 263/32 (2013.01) ; C07D 263/42 (2013.01) ; C07D 277/34 (2013.01) ; C07D 333/20 (2013.01) ; C07D 401/04 (2013.01) ; C07D 401/12 (2013.01) ; C07D 409/04 (2013.01) ; C07D 413/04 (2013.01) ; C07D 417/04 (2013.01) ; C07C 2601/02 (2017.05) ; C07C 2601/14 (2017.05) ; C12N 9/99 (2013.01) ; C12N 15/09 (2013.01) ;
Abstract The present invention relates to a compound which may be useful as an agent for the prophylaxis or treatment of cancer, hepatitis, hepatic fibrosis, fatty liver and the like.
Find Patent Forward Citations
Click to load US Patent References
Cite this Patent (APA, Harvard, BibTeX)
Mizojiri, Ryo. (2019). Monocyclic compound (U.S. Patent No. 10252997). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10252997
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile